All In Biotech

Free tool

FAERS Monitor: Cosentyx

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 761349 or its brand name (Cosentyx, Secukinumab). Reports on generic versions are filed under their own applications.

Reports

161,904

Serious

65,379

40% of reports

Hospitalization

22,508

Death reported

9,022

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective29,381
  • psoriasis22,918
  • pain16,854
  • arthralgia15,102
  • fatigue10,786
  • psoriatic arthropathy10,387
  • malaise9,598
  • pruritus9,542
  • rash9,297
  • condition aggravated8,697
  • diarrhoea8,168
  • nasopharyngitis7,955
  • headache7,440
  • pain in extremity7,432
  • off label use7,053

Reports by year received

View as table
YearReports
20121
20133
201411
20152,812
20166,260
201711,695
201820,874
201921,465
202022,595
202117,026
202217,155
202317,264
202411,057
20259,204
20264,482

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,892,255 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
psoriatic arthropathySignal10,38744.343.4327,970
psoriasisSignal22,91827.427.1484,286
nasopharyngitisSignal7,9555.85.730,603
arthralgiaSignal15,1024.94.845,494
condition aggravatedSignal8,6973.83.717,652
painSignal16,8543.63.632,275
pain in extremitySignal7,4323.33.312,014
pruritusSignal9,5423.33.215,039
drug ineffectiveSignal29,3812.92.939,212
malaiseSignal9,5982.92.811,800
rashSignal9,2972.82.810,825
fatigue10,7861.81.84,011
diarrhoea8,1681.71.62,141
headache7,4401.51.51,470
off label use7,0531.01.015

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.